Nonproliferative diabetic retinopathy (NPDR) — also called background retinopathy — is a microvascular complication of diabetes mellitus in which chronic hyperglycemia damages the small blood vessels (capillaries) supplying the retina. The hallmark distinguishing NPDR from its more advanced counterpart, proliferative diabetic retinopathy (PDR), is the complete absence of retinal neovascularization (new, abnormal blood vessel growth). Pathophysiology begins with loss of pericytes (structural support cells lining retinal capillaries), followed by breakdown of the blood-retinal barrier, formation of microaneurysms (focal outpouchings of capillary walls), and progressive capillary occlusion leading to retinal ischemia. As ischemia worsens, VEGF (vascular endothelial growth factor) is upregulated — the molecular trigger that drives conversion to PDR. NPDR is classified into three stages by the ETDRS (Early Treatment Diabetic Retinopathy Study) severity scale and international consensus:
More microaneurysms, dot-and-blot hemorrhages, hard exudates, cotton-wool spots
Severe NPDR
”4-2-1 Rule”: hemorrhages/MAs in all 4 quadrants, OR venous beading in ≥2 quadrants, OR IRMA in ≥1 quadrant
Diabetic macular edema (DME) — fluid accumulation at the macula — can occur at any stage of NPDR and is the leading cause of vision loss in diabetic patients. Management is primarily through glycemic control, blood pressure management, and monitoring; anti-VEGF injections (e.g., Eylea, Lucentis, Avastin) are the standard of care for center-involving DME.
Referring to the excessive urination characteristic of diabetes; from dia- (“through”) + bainein (“to go”)
Retinopathy
Latin rete (“net”) + Greek -pathy (pathos, “disease/suffering”)
“disease of the retina” — the net-like layer of sensory tissue at the back of the eye
The full term was codified in the ophthalmology literature primarily through the ETDRS studies of the 1980s, which formally established the staging criteria still used today.
ALIASES / ABBREVIATIONS / RELATED TERMS
Term
Meaning
NPDR
Standard abbreviation for nonproliferative diabetic retinopathy
Optical coherence tomography — gold standard imaging for detecting and monitoring DME
CODING CONTEXT — ICD-10-CM/CPT
⚠️ Critical ICD-10 Coding Rule for Diabetic Retinopathy:
In ICD-10-CM, diabetic retinopathy is always coded within the diabetes category (E10.-, E11.-, etc.) — never as a standalone retinal code. The diabetes code captures both the underlying condition and its manifestation. Laterality is required at the 7th character level. Do not additionally assign a separate H-code for the retinopathy unless a distinct, unrelated retinal condition also exists.
ICD-10 Code Structure for NPDR:E[DM type].[stage][macular edema flag][laterality]
5th digit: Type of NPDR (3 = mild, 4 = moderate, 5 = severe — within the retinopathy subcategory)
6th digit: 1 = with macular edema; 9 = without macular edema
7th digit: 1 = right eye; 2 = left eye; 3 = bilateral; 9 = unspecified eye
Remote imaging for detection of retinal disease; image acquisition and transmission, unilateral or bilateral, with interpretation by a physician or QHP
Remote imaging for monitoring of retinal disease; image acquisition and transmission, unilateral or bilateral, with interpretation by a physician or QHP
Imaging of retina for detection or monitoring of disease; point-of-care automated analysis, unilateral or bilateral, with interpretation by physician or QHP
Destruction of localized lesion of retina; photocoagulation — focal/grid laser for DME
Key Coding Tips
Laterality is mandatory — always code to the 7th character specifying right (1), left (2), bilateral (3), or unspecified (9). Unspecified eye codes risk payer denial.
Macular edema status must be documented — the 6th character flip (e.g., E11.3311 vs. E11.3391) represents a clinically and financially significant distinction. Always verify with the operative/encounter note.
E11.319 (unspecified retinopathy) should only be used when the provider has not documented the stage — it is not preferred and will not satisfy HCC capture requirements.
NCCI bundles 92134 and 92250 — do not report both on the same date without modifier 59 and a documented distinct medical necessity for each (e.g., OCT for DME and fundus photography for a separate choroidal finding).
67028 (intravitreal injection) is bundled with many retinal laser procedures — confirm NCCI edits before billing together.
Long-term insulin use (Z79.4) and oral hypoglycemic use (Z79.84) should be coded additionally per ICD-10-CM instructional notes under the E10-E11 categories.
For inpatient coding (ICD-10-PCS): the retinal procedure (intravitreal injection, laser) requires a PCS procedure code from the Eye (0) body system, root operation Introduction or Destruction.
Severity of NPDR directly affects HCC mapping and RAF scores in risk-adjustment models — accurate severity coding (mild/moderate/severe) is essential for value-based care programs.